Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000010

Director sold 286,369 shares at an average $32.30 ($9,251,102)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Booth Bruce · Director

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-16 Sale : show line 1 in the form 10b5-1 −8,596 $30.15 $259,169 2,610,589 I
2025-10-16 Sale : show line 2 in the form 10b5-1 −1,804 $30.15 $54,391 749,860 I
2025-10-16 Sale : show line 3 in the form 10b5-1 −45,117 $31.69 $1,429,758 2,565,472 I
2025-10-16 Sale : show line 4 in the form 10b5-1 −9,470 $31.69 $300,104 740,390 I
2025-10-16 Sale : show line 5 in the form 10b5-1 −73,296 $32.84 $2,407,041 2,492,176 I
2025-10-16 Sale : show line 6 in the form 10b5-1 −15,384 $32.84 $505,211 725,006 I
2025-10-16 Sale : show line 7 in the form 10b5-1 −12,888 $33.38 $430,201 2,479,288 I
2025-10-16 Sale : show line 8 in the form 10b5-1 −2,705 $33.38 $90,293 722,301 I
Open-market sales · 286,369 sh · avg $32.30 · $9,251,102
Loading xslF345X05/form4-10212025_011050.xml…